![Marc Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Wilson
No open positions remaining
Net worth: 4 M $ as of 30/06/2026
Profile
Marc J.
S.
Wilson formerly worked at Trius Therapeutics, Inc., as Accounting Director & Controller from 2010 to 2014, Cidara Therapeutics, Inc., as Chief Accounting Officer & Vice President from 2014 to 2018, and Crinetics Pharmaceuticals, Inc., as Chief Financial Officer from 2018 to 2025.
Mr. Wilson received his undergraduate degree from College of the Holy Cross (Massachusetts).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/07/2026 | 105,237 ( 0.1% ) | 4 M $ | 30/06/2026 |
Former positions of Marc Wilson
| Companies | Position | End |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Director of Finance/CFO | 28/02/2025 |
| CIDARA THERAPEUTICS | Comptroller/Controller/Auditor | 03/01/2018 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Comptroller/Controller/Auditor | 01/08/2014 |
Training of Marc Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
- Stock Market
- Insiders
- Marc Wilson
